|
National Stock Number(NSN): 6505-01-611-2256 (6505016112256, 016112256)
| NIIN: |
01-611-2256 |
Item Name: |
IMIPENEM AND CILASTATIN FOR INJECTION |
INC: |
66649
|
| FSC: |
6505
|
Assignment Date: |
Sep-07-2012 |
CRIT: |
X |
IIG: |
66649 |
| ISC: |
5 |
Date Standardized: |
Sep-07-2012 |
HMIC: |
P |
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Jan-01-2017 |
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
3004.90.9185 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
4 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
3 |
| NIIN: |
01-332-4794 |
Item Name: |
IMIPENEM AND CILASTATIN FOR INJECTION |
| FSC: |
6505 |
Replacement Date: |
Jan-01-2017 |
|
INC: |
66649 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
248636 |
89875
|
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
342020 |
1DQP2
|
AMERICAN PHARMACEUTICAL PARTNERS |
H |
5 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
6505NCM128404 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC63323-0322-20 |
1DQP2
|
AMERICAN PHARMACEUTICAL PARTNERS |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
SMS |
Y |
|
M |
U |
0 |
A |
$126.01 |
PG |
|
C2201X- |
Nov-01-2016 |
H |
| DF |
SMS |
Y |
|
M |
U |
0 |
F |
$126.01 |
PG |
|
------- |
Nov-01-2016 |
H |
| DM |
SMS |
L |
Z |
M |
U |
0 |
M |
$126.01 |
PG |
|
1554--- |
Oct-01-2016 |
H |
| DN |
SMS |
Y |
|
M |
U |
0 |
N |
$126.01 |
PG |
|
9B----- |
Nov-01-2016 |
H |
| DS |
SMS |
Y |
N |
M |
U |
0 |
D |
$126.01 |
PG |
|
------- |
Nov-01-2016 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AJCN |
PROTECTIVE STORAGE FEATURE |
CONTROLLED ROOM TEMPERATURE |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
500.0 MILLIGRAMS IMIPENEM EQUIVALENT AND 500.0 MILLIGRAMS CILASTATIN EQUIVALENT |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
IMIPENEM AND CILASTATIN FOR INJECTION USP 500-500MG POWDER 10S |
| FEAT |
SPECIAL FEATURES |
500 MG IMIPENEM EQUIVALENT ACTIVE INGREDIENT AND 500 MG CILASTATIN EQUIVALENT ACTIVE INGREDIENT; STERILE POWDER FOR INJECTION; FOR IV ADMINISTRATION; 500 MG SINGLE DOSE VIALS; PRESERVATIVE-FREE; PACKAGE OF 10; STORE AT USP ROOM TEMPERATURE (68-77 DEG F) |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A911 |
|
Sep-07-2012 |
0 |
0 |
|
|
AM|GX |
AM|BN|GX |
| FSGM |
|
Sep-07-2012 |
0 |
0 |
|
|
GX|TT |
GX|SS|TT |
| MC55 |
|
Sep-07-2012 |
0 |
0 |
|
|
GX|PA |
GX|PA |
| N9BL |
|
Sep-07-2012 |
0 |
0 |
|
|
GX |
GH|GX |
|